| Application no. and date | 18201334.2 (espacenet) (Federated) (European Patent Register), 20140804 | | Patent/reg. no. and date | DK/EP 3456339, 20211020 | | Publication date | 20190320 | | Priority no. and date | GB 201313987, 20130805, US 201361862213 P, 20130805, GB 201403297, 20140225 | | EP pub. no. and date |
EP 3456339 20190320 | | Effective date | | | Applicant/owner | immatics biotechnologies GmbH, Paul-Ehrlich-Strasse 15
72076 Tübingen, DE | | Applicant ref. no. | P3083DKEP | | Inventor | Weinschenk, Toni, Im Morgenrain 15
73773 Aichwald, DE,
FRITSCHE, Jens, Lärchenweg 11
72144 Dusslingen, DE,
SONG, Colette, Willi-Baumeister-Weg 21
73760 Ostfildern, DE,
Walter, Steffen, 2901 Wroxton Road
Houston, TX Texas 77005, US,
SINGH, Harpreet, HeckscherstraÃYe 25a
80804 München, DE | | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 39/00 (2006.01) , C07K 7/06 (2006.01) , C12N 5/0783 (2010.01) | | Title | Hidtil ukendt immunterapi mod flere forskellige tumorer, såsom lungecancer, herunder NSCLC | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
